{"info": {"address1": "One Amgen Center Drive", "city": "Thousand Oaks", "state": "CA", "zip": "91320-1799", "country": "United States", "phone": "805 447 1000", "fax": "805 447 1010", "website": "https://www.amgen.com", "industry": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Beh\u00e7et's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.", "fullTimeEmployees": 25200, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert A. Bradway", "age": 59, "title": "Chairman, CEO & Pres", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 5487475, "exercisedValue": 0, "unexercisedValue": 43693576}, {"maxAge": 1, "name": "Mr. Peter H. Griffith", "age": 63, "title": "Exec. VP & CFO", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 2574004, "exercisedValue": 0, "unexercisedValue": 245771}, {"maxAge": 1, "name": "Mr. Esteban  Santos", "age": 54, "title": "Exec. VP of Operations", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 2521941, "exercisedValue": 0, "unexercisedValue": 8232750}, {"maxAge": 1, "name": "Dr. David M. Reese M.D.", "age": 59, "title": "Exec. VP of R&D", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 2833393, "exercisedValue": 0, "unexercisedValue": 4932458}, {"maxAge": 1, "name": "Mr. Murdo  Gordon", "age": 55, "title": "Exec. VP of Global Commercial Operations", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 2717562, "exercisedValue": 0, "unexercisedValue": 2469817}, {"maxAge": 1, "name": "Ms. Linda H. Louie", "title": "VP of Fin. & Chief Accounting Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mike  Zahigian", "title": "Sr. VP & Chief Information Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Arvind  Sood", "title": "VP of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan P. Graham", "age": 61, "title": "Exec. VP, Gen. Counsel & Sec.", "yearBorn": 1961, "fiscalYear": 2019, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nancy A. Grygiel", "age": 54, "title": "Sr. VP of Worldwide Compliance & Bus. Ethics and Chief Compliance Officer", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 8, "compensationRisk": 1, "shareHolderRightsRisk": 1, "overallRisk": 1, "governanceEpochDate": 1680307200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 248.07, "open": 248.37, "dayLow": 244.695, "dayHigh": 249.01, "regularMarketPreviousClose": 248.07, "regularMarketOpen": 248.37, "regularMarketDayLow": 244.695, "regularMarketDayHigh": 249.01, "dividendRate": 8.52, "dividendYield": 0.0343, "exDividendDate": 1684281600, "payoutRatio": 0.6408, "fiveYearAvgDividendYield": 2.86, "beta": 0.641522, "trailingPE": 20.321222, "forwardPE": 13.159892, "volume": 1638773, "regularMarketVolume": 1638773, "averageVolume": 2508877, "averageVolume10days": 1990660, "averageDailyVolume10Day": 1990660, "bid": 0.0, "ask": 0.0, "bidSize": 800, "askSize": 1200, "marketCap": 131464970240, "fiftyTwoWeekLow": 223.3, "fiftyTwoWeekHigh": 296.67, "priceToSalesTrailing12Months": 4.9943004, "fiftyDayAverage": 239.0154, "twoHundredDayAverage": 251.8326, "trailingAnnualDividendRate": 7.76, "trailingAnnualDividendYield": 0.031281494, "currency": "USD", "enterpriseValue": 162798485504, "profitMargins": 0.24891001, "floatShares": 532886926, "sharesOutstanding": 533976000, "sharesShort": 7833483, "sharesShortPriorMonth": 7368918, "sharesShortPreviousMonthDate": 1677542400, "dateShortInterest": 1680220800, "sharesPercentSharesOut": 0.0147, "heldPercentInsiders": 0.00217, "heldPercentInstitutions": 0.7986, "shortRatio": 3.01, "shortPercentOfFloat": 0.0147, "impliedSharesOutstanding": 0, "bookValue": 6.856, "priceToBook": 35.894108, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "earningsQuarterlyGrowth": -0.149, "netIncomeToCommon": 6552000000, "trailingEps": 12.11, "forwardEps": 18.7, "pegRatio": 8.59, "lastSplitFactor": "2:1", "lastSplitDate": 943228800, "enterpriseToRevenue": 6.185, "enterpriseToEbitda": 12.072, "52WeekChange": -0.03637719, "SandP52WeekChange": -0.06829989, "lastDividendValue": 2.13, "lastDividendDate": 1676332800, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "AMGN", "underlyingSymbol": "AMGN", "shortName": "Amgen Inc.", "longName": "Amgen Inc.", "firstTradeDateEpochUtc": 424704600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9376b97e-b428-3231-ba0b-142b20481cb4", "messageBoardId": "finmb_24816", "gmtOffSetMilliseconds": -14400000, "currentPrice": 246.09, "targetHighPrice": 325.0, "targetLowPrice": 175.0, "targetMeanPrice": 257.67, "targetMedianPrice": 265.0, "recommendationMean": 2.7, "recommendationKey": "hold", "numberOfAnalystOpinions": 21, "totalCash": 9304999936, "totalCashPerShare": 17.426, "ebitda": 13486000128, "totalDebt": 39639998464, "quickRatio": 1.001, "currentRatio": 1.414, "totalRevenue": 26322999296, "debtToEquity": 1082.764, "revenuePerShare": 48.928, "returnOnAssets": 0.099659994, "returnOnEquity": 1.26474, "grossProfits": 19917000000, "freeCashflow": 8751375360, "operatingCashflow": 9720999936, "earningsGrowth": -0.109, "revenueGrowth": -0.001, "grossMargins": 0.75664, "ebitdaMargins": 0.51233, "operatingMargins": 0.38252, "financialCurrency": "USD", "trailingPegRatio": 1.3938}, "news": [{"uuid": "d7cbeae9-518b-3121-8bad-19e5a1634d5d", "title": "These 4 Measures Indicate That Amgen (NASDAQ:AMGN) Is Using Debt Reasonably Well", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/4-measures-indicate-amgen-nasdaq-120023592.html", "providerPublishTime": 1681819223, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CFs_WULfFYYyM1iyv.feAw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/l1LHAzUzNTUlYF0q.vdO5A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AMGN"]}, {"uuid": "a01561d7-7b92-35d3-8aaf-3bc5fead86b5", "title": "15 Cheapest Countries for Retirement", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/15-cheapest-countries-retirement-125033139.html", "providerPublishTime": 1681735833, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pSJvAowUUM2rtKmpEt0tNw--~B/aD02MDA7dz02NDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ff8a3b218f35aa78ead19f2e51a536e2", "width": 644, "height": 600, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/hG5ZACm0qSCNEM4uTwsUwA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ff8a3b218f35aa78ead19f2e51a536e2", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["WELL", "AMGN"]}, {"uuid": "1cef805e-a5e9-39f1-87b4-e4af4959883d", "title": "Merck to Acquire Prometheus Biosciences", "publisher": "The Wall Street Journal", "link": "https://finance.yahoo.com/m/1cef805e-a5e9-39f1-87b4-e4af4959883d/merck-to-acquire-prometheus.html", "providerPublishTime": 1681683600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/yps4vQD8_MT.ArbbZtkIJw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/e5fa7a8ac49f1ac7fbc29919da762252", "width": 1280, "height": 640, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/x5kV40fpWF2weWxfWRG8Cw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/e5fa7a8ac49f1ac7fbc29919da762252", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["RXDX", "AMGN", "MRK", "ABBV"]}, {"uuid": "e2003b1b-46fc-34e5-a007-4bf7a313350b", "title": "Is Arrowhead Pharmaceuticals a Buy Now?", "publisher": "Motley Fool", "link": "https://finance.yahoo.com/m/e2003b1b-46fc-34e5-a007-4bf7a313350b/is-arrowhead-pharmaceuticals.html", "providerPublishTime": 1681636860, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/gaeoAiRJrg1CCjUYmFkROA--~B/aD0xNDE0O3c9MjEyMTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/a26eeb8ba3bcd454a5f60c838374f584", "width": 2121, "height": 1414, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/52RonxVJlkE9hWC66kMAow--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/a26eeb8ba3bcd454a5f60c838374f584", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ARWR", "GSK", "AMGN"]}, {"uuid": "03bac282-5ebc-3f2d-9bdd-46fbe1c4eb76", "title": "Amgen (AMGN) Gains But Lags Market: What You Should Know", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/amgen-amgn-gains-lags-market-215009799.html", "providerPublishTime": 1681422609, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/UPInF06X6fJkTqeimnpZuQ--~B/aD03NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba", "width": 900, "height": 745, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/tlKVbaKmxwUbiS87UIMwQA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AMGN", "^GSPC"]}, {"uuid": "9ec77b10-bdb4-3506-957f-39c40e8ad4ad", "title": "How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own", "publisher": "Fortune", "link": "https://finance.yahoo.com/news/horizon-therapeutics-sold-amgen-27-160000608.html", "providerPublishTime": 1681401600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/i15qX4jBIiHeg41eAsSzPA--~B/aD0xMzY1O3c9MjA0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/acaf63bc6621c1a69d8553b9d13cfd38", "width": 2048, "height": 1365, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/fOI._E3Uw2ldNDibYAh3pA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/fortune_175/acaf63bc6621c1a69d8553b9d13cfd38", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AMGN"]}, {"uuid": "6ed3a22d-2377-471b-bc1c-57ae9e64df5b", "title": "Medical research has driven 'the last 200 years of economic expansion': Michael Milken", "publisher": "Yahoo Finance", "link": "https://finance.yahoo.com/news/medical-research-has-driven-the-last-200-years-of-economic-expansion-michael-milken-202057241.html", "providerPublishTime": 1681330857, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/2b5E_Qfms8jki0dKJTeU2A--~B/aD0yNDAwO3c9MzYwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2023-03/dbeae360-d96d-11ed-97ff-112de5cef043", "width": 3600, "height": 2400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/LetxXQe1eWV60MFfsadlPw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/os/creatr-uploaded-images/2023-03/dbeae360-d96d-11ed-97ff-112de5cef043", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AMGN", "RHHBF", "RHHBY", "RHHVF"]}, {"uuid": "f8f1caa5-7f14-34e1-9ec6-9e6773c3f455", "title": "Amgen Inc. (NASDAQ:AMGN) is a favorite amongst institutional investors who own 78%", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/amgen-inc-nasdaq-amgn-favorite-140018577.html", "providerPublishTime": 1681221618, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/CFs_WULfFYYyM1iyv.feAw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/l1LHAzUzNTUlYF0q.vdO5A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AMGN"]}]}